HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia

Developmental Dynamics

Volumn 236, Issue 4, 2007, Pages 951-960

  Shaut, Carley A ^a   Saneyoshi, Chie ^a   Morgan, Emily A ^a   Knosp, Wendy M ^b   Sexton, Diane R ^c   Stadler, H Scott ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UCSF Mission Bay Campus ^*  (United States)

^c SHRINERS HOSPITAL FOR CHILDREN   (United States)

Author keywords

EphA6; EphA7; Genital tubercle; Hoxa13; Hypospadias; Vascular endothelia

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA13; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; EMBRYO; EPHA6 GENE; EPHA7 GENE; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENITAL SYSTEM; HOMOZYGOSITY; HYPOSPADIAS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; VASCULAR ENDOTHELIUM;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENITALIA; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTOR, EPHA6; RECEPTOR, EPHA7; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSFECTION;

MUS;

EID: 34247347853     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21077     Document Type: Article

References (58)

1. Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U, Klein R. 2001. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 104:57-69.
2. Baskin LS. 2000. Hypospadias and urethral development. J Urol 163:951-956.
3. Baskin LS, Erol A, Li YW, Cunha GR. 1998. Anatomical studies of hypospadias. J Urol 160:1108-1115; discussion 1137.
4. Brown A, Yates PA, Burrola P, Ortuno D, Vaidya A, Jessell TM, Pfaff SL, O'Leary DD, Lemke G. 2000. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell 102:77-88.
5. Chan J, Mably JD, Serluca FC, Chen JN, Goldstein NB, Thomas MC, Cleary JA, Brennan C, Fishman MC, Roberts TM. 2001. Morphogenesis of prechordal plate and notochord requires intact Eph/ephrin B signaling. Dev Biol 234:470-482.
6. Chen J, Ruley HE. 1998. An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins. J Biol Chem 273:24670-24675.
7. Cheng N, Brantley DM, Chen J. 2002. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13:75-85.
8. Cohn EJ, Edsall JT, editors. 1943. Proteins amino acids and peptides. New York: Reinhold Publishing Corp. p 370.
9. Cooke JE, Kemp HA, Moens CB. 2005. EphA4 is required for cell adhesion and rhombomere-boundary formation in the zebrafish. Curr Biol 15:536-542.
10. Davy A, Soriano P. 2005. Ephrin signaling in vivo: look both ways. Dev Dyn 232:1-10.
11. Davy A, Aubin J, Soriano P. 2004. Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18:572-583.
12. Dravis C, Yokoyama N, Chumley MJ, Cowan CA, Silvany RE, Shay J, Baker LA, Henkemeyer M. 2004. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol 271:272-290.
13. Egea J, Nissen UV, Dufour A, Sahin M, Greer P, Kullander K, Mrsic-Flogel TD, Greenberg ME, Kiehn O, Vanderhaeghen P, Klein R. 2005. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 47:515-528.
14. Eichmann A, Le Noble F, Autiero M, Carmeliet P. 2005a. Guidance of vascular and neural network formation. Curr Opin Neurobiol 15:108-115.
15. Eichmann A, Yuan L, Moyon D, Lenoble F, Pardanaud L, Breant C. 2005b. Vascular development: from precursor cells to branched arterial and venous networks. Int J Dev Biol 49:259-267.
16. Erickson T, Scholpp S, Brand M, Moens CB, Jan Waskiewicz A. 2006. Pbx proteins cooperate with Engrailed to pattern the midbrain-hindbrain and diencephalic-mesencephalic boundaries. Dev Biol 301:504-517.
17. Gallentine ML, Morey AF, Thompson IM Jr. 2001. Hypospadias: a contemporary epidemiologic assessment. Urology 57: 788-790.
18. Gerety SS, Wang HU, Chen ZF, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4: 403-414.
19. Giwercman A, Carlsen E, Keiding N, Skakkebaek NE. 1993. Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect 101(Suppl 2):65-71.
20. Harbott LK, Nobes CD. 2005. A key role for Abl family kinases in EphA receptor-mediated growth cone collapse. Mol Cell Neurosci 30:1-11.
21. Hinck L. 2004. The versatile roles of "axon guidance" cues in tissue morphogenesis. Dev Cell 7:783-793.
22. Holmberg J, Clarke DL, Frisen J. 2000. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature 408:203-206.
23. Huffman JL, Mokashi A, Bachinger HP, Brennan RG. 2001. The basic helix-loop-helix domain of the aryl hydrocarbon receptor nuclear transporter (ARNT) can oligomerize and bind E-box DNA specifically. J Biol Chem 276:40537-40544.
24. Hunter SG, Zhuang G, Brantley-Sieders D, Swat W, Cowan CW, Chen J. 2006. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Mol Cell Biol 26: 4830-4842.
25. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, Weber RJ, Haussler D, Kent WJ. 2003. The UCSC Genome Browser Database. Nucleic Acids Res 31:51-54.
26. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12:996-1006.
27. Kent WJ, Hsu F, Karolchik D, Kuhn RM, Clawson H, Trumbower H, Haussler D. 2005. Exploring relationships and mining data with the UCSC Gene Sorter. Genome Res 15:737-741.
28. Klagsbrun M, Eichmann A. 2005. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16:535-548.
29. Knosp WM, Scott V, Bachinger HP, Stadler HS. 2004. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis. Development 131:4581-4592.
30. Kodadek T. 1998. Mechanistic parallels between DNA replication, recombination and transcription. Trends Biochem Sci 23:79-83.
31. Lavrrar JL, Farnham PJ. 2004. The use of transient chromatin immunoprecipitation assays to test models for E2F1-specific transcriptional activation. J Biol Chem 279:46343-46349.
32. Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, Pfaff SL. 2005. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 121: 127-139.
33. Marston DJ, Goldstein B. 2006. Actin-based forces driving embryonic morphogenesis in Caenorhabditis elegans. Curr Opin Genet Dev 16:392-398.
34. McBride JL, Ruiz JC. 1998. Ephrin-A1 is expressed at sites of vascular development in the mouse. Mech Dev 77:201-204.
35. McCabe CD, Innis JW. 2005. A genomic approach to the identification and characterization of HOXA13 functional binding elements. Nucleic Acids Res 33:6782-6794.
36. Moens CB, Selleri L. 2006. Hox cofactors in vertebrate development. Dev Biol 291: 193-206.
37. Morgan EA, Nguyen SB, Scott V, Stadler HS. 2003. Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia. Development 130:3095-3109.
38. Mortlock DP, Innis JW. 1997. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 15:179-180.
39. Myers C, Charboneau A, Boudreau N. 2000. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 148:343-351.
40. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB. 2000. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19:6043-6052.
41. Pasquale EB. 2005. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6:462-475.
42. Paulozzi LJ, Erickson JD, Jackson RJ. 1997. Hypospadias trends in two US surveillance systems. Pediatrics 100:831-834.
43. Perriton CL, Powles N, Chiang C, Maconochie MK, Cohn MJ. 2002. Sonic hedgehog signaling from the urethral epithelium controls external genital development. Dev Biol 247:26-46.
44. Salsi V, Zappavigna V. 2006. Hoxd13 and Hoxa13 directly control the expression of the EphA7 Ephrin tyrosine kinase receptor in developing limbs. J Biol Chem 281: 1992-1999.
45. Scott V, Morgan EA, Stadler HS. 2005. Genitourinary functions of Hoxa13 and Hoxd13. J Biochem (Tokyo) 137:671-676.
46. Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, Bazalakova M, Neve RL, Corfas G, Debant A, Greenberg ME. 2001. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 105:233-244.
47. Shou S, Scott V, Reed C, Hitzemann R, Stadler HS. 2005. Transcriptome analysis of the murine forelimb and hindlimb autopod. Dev Dyn 234:74-89.
48. Stadler HS. 2003. Modelling genitourinary defects in mice: an emerging genetic and developmental system. Nat Rev Genet 4:478-482.
49. Stadler HS, Solursh M. 1994. Characterization of the homeobox-containing gene GH6 identifies novel regions of homeobox gene expression in the developing chick embryo. Dev Biol 161:251-262.
50. Stadler HS, Higgins KM, Capecchi MR. 2001. Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development 128:4177-4188.
51. Stern AM, Gall JC Jr, Perry BL, Stimson CW, Weitkamp LR, Poznanski AK. 1970. The hand-food-uterus syndrome: a new hereditary disorder characterized by hand and foot dysplasia, dermatoglyphic abnormalities, and partial duplication of the female genital tract. J Pediatr 77: 109-116.
52. Svensson H, Reychman M, Troeng T, Aberg M. 1997. Staged reconstruction of hypospadias with chordee: outcome and costs. Scand J Plast Reconstr Surg Hand Surg 31:51-55.
53. Vashee S, Melcher K, Ding WV, Johnston SA, Kodadek T. 1998. Evidence for two modes of cooperative DNA binding in vivo that do not involve direct protein-protein interactions. Curr Biol 8:452-458.
54. Villaescusa JC, Verrotti AC, Ferretti E, Farookhi R, Blasi F. 2004. Expression of Hox cofactor genes during mouse ovarian follicular development and oocyte maturation. Gene 330:1-7.
55. Wahl S, Barth H, Ciossek T, Aktories K, Mueller BK. 2000. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol 149:263-270.
56. Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753.
57. Warot X, Fromental-Ramain C, Fraulob V, Chambon P, Dolle P. 1997. Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development 124:4781-4791.
58. Williams TM, Williams ME, Innis JW. 2005. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction. Dev Biol 277:457-471.